Exploring the effects and mechanism of peony pollen in treating benign prostatic hyperplasia

Exploring the effects and mechanism of peony pollen in treating benign prostatic hyperplasia

Paeonia suffruticosa is widely cultivated globally due to its medicinal and ornamental value. Peony pollen (PP) is commonly used in Chinese folk medicine to make tea to treat benign prostatic hyperplasia (BPH), but its molecular mechanism against BPH is yet to be comprehended. The objective of this...

Full description

Bibliographic Details
Main Authors:	Jun Mu, Junsheng Wu, Linrui Duan, Qian Yang, Xiaoting Liu, Huixin Bai, Yanhua Xie, Jie Li, Siwang Wang
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	Heliyon
Subjects:	Peony pollen Benign prostatic hyperplasia Network pharmacology Target prediction Molecular docking
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023094203

Similar Items

Pharmacological Effects and Potential Clinical Usefulness of Polyphenols in Benign Prostatic Hyperplasia
by: Kensuke Mitsunari, et al.
Published: (2021-01-01)

THE FACTORS ASSOCIATED WITH THE INCIDENCE OF BENIGN PROSTATIC HYPERPLASIA
by: sukron sukron
Published: (2022-07-01)

Is opium addiction a risk factor for benign prostatic hyperplasia?
by: Amin Abolhasani Foroughi, et al.
Published: (2023-03-01)

Benign Prostatic Hyperplasia in a 13-Year-Old Boy
by: Chrispine Onyango Oluoch, et al.
Published: (2023-04-01)

Survey of urologists over the management of benign prostatic hyperplasia in India
by: Meghna Pandey, et al.
Published: (2022-11-01)

Oxidative stress biomarkers in dogs with benign prostatic hyperplasia
by: Anna Domoslawska, et al.
Published: (2022-12-01)

Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolization
by: Matthias Boschheidgen, et al.
Published: (2023-03-01)

Correlation between prostate size and age of patients evaluated for symptomatic benign prostatic hyperplasia
by: Udoh EA, et al.
Published: (2020-01-01)

DOES HYPOGONADISM ON RESULTS TRANSURETHRAL RESECTION OF BENIGN PROSTATIC HYPERPLASIA?
by: A. V. Sigaev, et al.
Published: (2013-06-01)

Is There a Relationship between Androgenic Alopecia and Benign Prostatic Hyperplasia?
by: Ladan Dastgheib, et al.
Published: (2015-01-01)

Association of receptor expression with prostate volume in benign prostatic hyperplasia
by: Karli Sreenivasulu, et al.
Published: (2019-01-01)

EMBOLIZATION AND CHEMOEMBOLIZATION PROSTATIC ARTERIES OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: N. B. Tabynbaev, et al.
Published: (2017-05-01)

Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
by: Weronika Ratajczak, et al.
Published: (2022-01-01)

Adipocytokine levels in benign prostate hyperplasia and prostate cancer patients
by: Gokhan Temeltas, et al.
Published: (2017-09-01)

Impact of drug use on patient symptom score and quality of life in benign prostatic hyperplasia patients
by: Harshank Vishnubhai Patel, et al.
Published: (2022-01-01)

Robotic-assisted simple prostatectomy after prostatic arterial embolization for large benign prostate hyperplasia: Initial experience
by: Sung-Chul Kam, et al.
Published: (2022-09-01)

The effect of transurethral prostate resection due to benign prostate hyperplasia on sexual functions
by: Sedat Tastemur, et al.
Published: (2021-09-01)

Initial Experience With Transurethral Enucleation With Bipolar Energy for Benign Prostatic Hyperplasia
by: Dae Young Kim, et al.
Published: (2017-12-01)

Urodynamic studies in the surgical treatment of benign prostatic hyperplasia
by: Marcelo L. de Lima, et al.
Published: (2003-10-01)

Measurement of autophagy flux in benign prostatic hyperplasia in vitro
by: Sung-hee Oh, et al.
Published: (2020-06-01)

A MICROBIAL CONTAMINATION OF PROSTATIC TISSUE IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: Y. L. Naboka, et al.
Published: (2013-03-01)

Incidental Prostate Cancer in Patients Treated for Benign Prostate Hyperplasia in the Period of 21 Years
by: Matea Pirša, et al.
Published: (2018-01-01)

Experience in the use of MOSES technology for endoscopic treatment of benign prostatic hyperplasia
by: K. S. Peshekhonov, et al.
Published: (2020-12-01)

INTERVENTIONAL SURGERY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
by: A. I. Neymark, et al.
Published: (2015-09-01)

Metabolic Syndrome and Benign Prostatic Hyperplasia/What Component of Metabolic Syndrome Is Related to Benign Prostatic Hyperplasia?
by: Bahar Arıcan Tarım, et al.
Published: (2023-09-01)

Acute urinary retention in benign prostatic hyperplasia: Risk factors and current management
by: K Muruganandham, et al.
Published: (2007-01-01)

Etiopathogenesis of benign prostatic hypeprlasia
by: Jie Tang, et al.
Published: (2009-01-01)

Relationship between Apparent Diffusion Coefficient Distribution and Cancer Grade in Prostate Cancer and Benign Prostatic Hyperplasia
by: Shigeyoshi Saito, et al.
Published: (2022-02-01)

Review of the role of pyroptosis in benign prostatic hyperplasia in old males
by: CHEN Zixuan, et al.
Published: (2023-12-01)

Identification of Differently Expressed miRNAs and Genes between Benign Prostatic Hyperplasia and Prostate Cancer
by: Yuqing Huang, MD, Cui Lei, BS, Xinyu Zhao, PhD, Jing Xiao, PhD, Xian-Quan Shi, PhD
Published: (2024-03-01)

Effect of preoperative prostate volume on the improvement of lower urinary tract symptoms in patients with benign prostatic hyperplasia undergoing transurethral resection of prostate
by: Behzad Lotfi, et al.
Published: (2020-04-01)

In Vivo and in Silico Assessment of Ameliorative Effects of Xylopia aethiopica on Testosterone Propionate-Induced Benign Prostatic Hyperplasia
by: Udu A. Ibiam, et al.
Published: (2023-06-01)

Clinical significance of distally located periurethral calcification in patients with lower urinary tract symptoms of benign prostate hyperplasia
by: Seong Hyeon Yu, et al.
Published: (2023-01-01)

Pharmacological and nutritive support of patients with benign prostatic hyperplasia and chronic prostatitis
by: A. B. Bat'ko
Published: (2015-04-01)

Pharmacological and nutritive support of patients with benign prostatic hyperplasia and chronic prostatitis
by: A. B. Bat ,ko
Published: (2015-04-01)

Correlation between prostate volume and prostate-specific antigen in patients diagnosed with benign prostatic hyperplasia
by: Udoh EA, et al.
Published: (2020-12-01)

Minimal Invasive Methods in the Treatment of Benign Prostate Hyperplasia
by: Akif Erbin, et al.
Published: (2012-09-01)

URINARY TRACT INFECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA ADMITTED FOR PROSTATECTOMY
by: M.H. Kamran
Published: (2021-12-01)

Inhibitory Effect of Astaxanthin on Testosterone-Induced Benign Prostatic Hyperplasia in Rats
by: Liping Wang, et al.
Published: (2021-11-01)

Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
by: Lucia Muraca, et al.
Published: (2022-06-01)